HANLY ANN M. 4
4 · Vir Biotechnology, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
HANLY ANN M.
EVP & Chief Technology Officer
Transactions
- Award
Common Stock
2023-02-22+37,500→ 119,505 total - Sale
Common Stock
2023-02-23$25.97/sh−2,302$59,790→ 117,203 total - Award
Stock Option (Right to Buy)
2023-02-22+55,000→ 55,000 totalExercise: $27.01Exp: 2033-02-21→ Common Stock (55,000 underlying)
Holdings
- 11.52(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]Includes 532 shares of common stock acquired by the reporting person on May 31, 2022 pursuant to an employee stock purchase program.
- [F3]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F4]The shares are beneficially owned by the reporting person's spouse, for the benefit of a minor child.
- [F5]25% of the shares subject to the stock option vest and become exercisable on February 22, 2024, and the remainder vest in 36 equal monthly installments thereafter.